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ABSTRACT 
Background: Oral contraceptives provide highly reliable contraceptive protection even though 
imperfect use is considered, and are widely used worldwide. 
Objective: This study aimed to assess the effect of low dose combined oral contraceptive pills use 
on lipid profile levels in Sudanese women, and to find its correlation with age, BMI and duration of 
using oral contraceptive.  
Material and Methods: A clinically-based descriptive study was conducted during the period from 
May to October 2013. Sixty six women using low dose combined oral contraceptive were selected 
as a test group compared to sixty six apparently healthy non users as a control, attending the family 
planning center of Omdurman Maternity Hospital in Khartoum state, Sudan. Blood specimens were 
collected from both groups and serum levels of Total Cholesterol, Triglyceride and High Density 
Lipoprotein (HDL) were estimated and Low Density Lipoprotein (LDL) was calculated using 
Friedewaled equation. 
Results : Results showed a significant increase in the mean serum levels of  Total Cholesterol, 
Triglyceride and HDL in the test group compared with the control group (p <0.05) and  
insignificant increase  in the mean serum levels of LDL in the test group (P = 0.327). HDL levels 
decreased with age (P value 0.000) while Cholesterol, Triglyceride and LDL levels were not 
affected. The study also showed significant increase in Cholesterol, Triglyceride and decrease in 
HDL with duration of oral contraceptive use (P <0.05).The BMI was significantly higher in users 
than non-users (P 0.025). 
Conclusion: Combined oral contraceptive pills adversely affect the lipid profile. This may be due 
to drug responsiveness, as well as increased BMI. There isa correlation between duration of oral 
contraceptive use and lipid profile among the studied cases. 
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ontraception is the prevention of 
conception by contraception device, 
drug or chemical agents. It is widely 
used to provide better quality of life by 
helping families to manage their resources1. 
In the developed countries, where the rate of 
contraceptive use rate is very high,1700 of the 
358,000 maternal deaths is attributed to 
contraceptive    use2.   The    combination    of  
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different    concentrations  of   estrogen    and 
progestin are known as combined oral 
combined oral contraceptives (COCs). In the 
present study the composition of the oral 
contraceptive taken by the women was: 
Ethinyl Estradiol (EE) (0.03mg) and 
Levonorgestrel (0.15mg). In Women, several 
risk factors are associated with development 
of cardiovascular disease, such as family 
history, obesity, smoking, unfavorable lipid 
profiles, high levels of homocystein and 
fibrinogen, physical inactivity, use of oral 
contraceptives (OC), diabetes mellitus, 
hypertension and genetic factors3. Many 
studies have reported a lower incidence of 
atherosclerosis and cardiovascular diseases in 
premenopausal women compared to age 
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matched mendue to the cardio protective 
action of estrogen4, 5.In the last five decades 
studies demonstrated that the levels of HDL 
cholesterol are inversely related to the clinical 
events that predispose atherosclerosis and 
cardiovascular diseases, whereas the levels of 
LDL cholesterol are directly related to these 
events6, 7.Estrogenas steroids able to 
promoting the protective actions, mainly it 
decreases the hepatic lipase, which degrades 
HDL so it result in increases HDL and 
decreases the production of LDL (Although 
the protective effect which done by the 
estrogen, progesterone may play an adverse 
role which influence the metabolism of the 
lipids9.Progestogens,increase the activity of 
hepatic lipases by alterating on the effect of 
estrogen on lipids profile, result in promoting 
a reversion in the increase of HDL10.  
So this study aimed to evaluate the possible 
effects of Oral contraceptives among users. 
MATERIALS and METHODS:  
A clinically-based cross-sectional descriptive
 study was conducted during the period from 
May to October 2013.In the present study the 
composition of the oral contraceptive taken 
by the women was: Ethinyl Estradiol (EE) 
(0.03mg) and Levonorgestrel (0.15mg).  Sixty 
six women attending the Family Planning 
Center of Omdurman Maternity Hospital in 
Khartoum state, Sudan and using low dose 
combined oral contraceptive were selected as 
a test group attending the Family Planning 
Center of Omdurman Maternity Hospital in 
Khartoum state, Sudan. The test group was 
compared with a control group which 
included 66 apparently healthy women (non-
users). Blood specimens were collected from 
both groups and serum levels of Total 
Cholesterol, Triglyceride and HDL were 
estimated and LDL was calculated using 
Friedewaled equation (LDL =cholesterol – 
(TG ÷5+ HDL).Ages of the test group were 
matched with the control group. The BMI was 
calculated as weight (kg) divided by squared 
height (m2). Serum Cholesterol, Triglyceride 
and HDL were measured by enzymatic 
 
Table (1): Comparison of mean Total Cholesterol, Triglycerides, HDL and LDL between study 
group and control group. 
 






 P value 
Cholesterol 144 ± 19 143 ± 25 0.961 
Triglyceride 111 ± 14 113 ± 21 0.786 
High density lipoprotein  42  ± 4 37  ± 4  0.000 
Low density lipoprotein 79  ± 19 83 ± 22 0.464 
 
Table 3: Body mass index (BMI) of the study population. 
Pvalue Control group(mean ± SD)  Study group (mean ± SD) BMI 
0.286 21±1.7     n   = 54 22±1.7    n  = 40 Normal 
0.116 27±1.3     n  = 12  26±1.3   n  = 54 Over weight 
0.025 22.9±2.7   n  = 66 23.9± 2.7   n  = 66 Total 
People with BMI=18.5—24.9 were considered to have normal weight, people with BMI=25.0—29.9 
were classified overweight. 
Variables 
Study group 
 (mean ± SD) 
Control group 
(mean ± SD) 
P value 
Cholesterol 143 ± 21 135 ± 19 0.026 
Triglyceride 112 ± 17 95 ± 22 0.000 
High density lipoprotein 40 ± 4 38 ± 5 0.038 
Low density lipoprotein 81 ± 20 77 ± 17 0.327 
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methods using semi- automated analyze 
Mindary BA-88 A.  
Statistical Package for Social Science (SPSS 
version 19) computer software was used for 
data analysis. Means ± SD were calculated. 
Independent T-test and Persons’ correlation 
were used (significance level was set             
at P> 0.05). 
RESULTS:  
In this study the test group was composed of 
66 contraceptive user women while the 
control group was composed of 66 non user 
women.  
There is significant difference between the 
mean of Cholesterol, Triglyceride and High 
density lipoprotein in test group compared to
 control group. The Low density lipoprotein 
was also insignificantly higher in users than 
non- users as shown in Table (1).  The oral 
contraceptive users were sub divided into two 
groups according to age; group 1 (25-34) 
years old and group 2(35-45). HDL level was 
significantly higher in oral contraceptive 
users group 1 compared with group 2, while 
mean concentrations of Cholesterol, 
Triglyceride and LDL were not significantly 
altered (Table 2).Table (3)shows significant 
elevation in body mass index in users than 
non-users. There is statically significant 
relationship between the duration of 
contraceptive use and the concentration of 




Figure (1): The correlation between duration 
of oral contraceptive use and the 
concentration of Total Cholesterol (r0.607, 
p0,000).  
 
Figure (2): The correlation between duration 
of oral contraceptive use and the 
concentration of Triglyceride (r0.518, p 
0,000). 
 
  Figure (3): The correlation between duration 
of oral contraceptive use and the 
concentration of High Density Lipoprotein 
(r= 0. 450, p 0,000). 
 
Figure (4): The correlation between duration 
of oral contraceptive use and the 
concentration of serum Low density 
lipoprotein (r = 0.100, p= 0,424).
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DISCUSSION: 
The major health risks of oral contraceptives 
are cardiovascular diseases particularly 
coronary artery disease, stroke and venous 
thrombo embolism11,12.The present study 
aimed to assess the lipid profile levels in 
Sudanese women using low dose combined 
oral contraceptive pills. 
In this study low dose combined oral 
contraceptives users show a significant 
increase in Cholesterol, Triglycerides and 
HDL in user as compared to control (P 0.05). 
This is mainly due to the effect of estrogen as 
it increases liver lipogenesis which results in 
elevated levels of Triglycerides (TG) and 
HDL. It has been suggested that the TG 
changes are due to the induction by estrogens 
of a hepatic microsomal enzyme that limits 
the rate of TG synthesis. This study agrees 
with a study done by F Nazet.al13, who 
revealed that oral estrogens and progestins in 
hormonal contraceptives have been shown to 
increase Cholesterol and TG, HDL and LDL.  
Furthermore, HDL levels decreased with age 
(p 0.000). This agrees with a study done by 
Aldrighi JM et al14.  
Also the study found that there was a 
significant increase in Cholesterol and TG 
and significantly decreased HDL with 
duration of contraceptive use. The present 
study supports the earlier studies15.Ourstudy 
showed significant difference among both 
study groups with respect to BMI. These 
findings were very consistent with the 
findings that oral contraceptive intake 
increases appetite and abnormal high 
concentrations of serum lipids among 
women16.  Weight gain might be also related 
to a reduction in physical activity. 
Progesterone, however, in the oral 
contraceptive causes an increase in an 
appetite and fat deposits17. Nevertheless, 
obese women should look for other methods 
of contraception. 
CONCLUSION: 
This study concluded that in Sudanese 
women using low dose oral contraceptive 
pills, the levels of Cholesterol and 
Triglycerides were significantly increased in 
users as compared to non-users with 
significant correlation with duration of use 
but not affected by age .In addition, it 
showed significant increase in High density 
lipoprotein in users compared to non -users 
with negative correlation with duration of 
oral contraceptive use and decrease in High 
density lipoprotein levels with age. Low 
Density Lipoprotein levels did not differ 
between the two groups and was not affected 
by age and duration of contraceptive use. 
Moreover, the results showed that the BMI 
was significantly higher in users than non-
users.  
The authors recommended that lipid profile 
should be estimated before and during the 
course of combined oral contraceptives. 
Awareness sessions on health eating pattern 
for mothers who are going on oral 
contraceptive should be implemented in 
schools, audio-vision systems and local 
organizations. Monitoring of BMI as well as 
biochemical examinations has to be carried 
out monthly for oral contraceptive taking 
women.  
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